• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主与 SARS-CoV-2 的较量:固有免疫与病毒逃逸策略。

The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.

机构信息

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

出版信息

Mol Ther. 2022 May 4;30(5):1869-1884. doi: 10.1016/j.ymthe.2022.02.014. Epub 2022 Feb 14.

DOI:10.1016/j.ymthe.2022.02.014
PMID:35176485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8842579/
Abstract

The SARS-CoV-2 virus, the pathogen causing COVID-19, has caused more than 200 million confirmed cases, resulting in more than 4.5 million deaths worldwide by the end of August, 2021. Upon detection of SARS-CoV-2 infection by pattern recognition receptors (PRRs), multiple signaling cascades are activated, which ultimately leads to innate immune response such as induction of type I and III interferons, as well as other antiviral genes that together restrict viral spread by suppressing different steps of the viral life cycle. Our understanding of the contribution of the innate immune system in recognizing and subsequently initiating a host response to an invasion of SARS-CoV-2 has been rapidly expanding from 2020. Simultaneously, SARS-CoV-2 has evolved multiple immune evasion strategies to escape from host immune surveillance for successful replication. In this review, we will address the current knowledge of innate immunity in the context of SARS-CoV-2 infection and highlight recent advances in the understanding of the mechanisms by which SARS-CoV-2 evades a host's innate defense system.

摘要

导致 COVID-19 的 SARS-CoV-2 病毒已造成超过 2 亿例确诊病例,截至 2021 年 8 月底,已导致全球超过 450 万人死亡。当模式识别受体(PRRs)检测到 SARS-CoV-2 感染时,会激活多个信号级联反应,最终导致先天免疫反应,如诱导 I 型和 III 型干扰素以及其他抗病毒基因,这些反应共同通过抑制病毒生命周期的不同步骤来限制病毒的传播。自 2020 年以来,我们对先天免疫系统在识别 SARS-CoV-2 并随后引发宿主反应方面的作用的理解迅速扩展。同时,SARS-CoV-2 已经进化出多种免疫逃避策略,以逃避宿主的免疫监视从而成功复制。在这篇综述中,我们将讨论先天免疫在 SARS-CoV-2 感染背景下的现有知识,并强调在理解 SARS-CoV-2 逃避宿主先天防御系统的机制方面的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/04625397ad9b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/3e5c092c0d78/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/b3c5a8aa0a5c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/c367c6fd1bca/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/c85cef05def2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/04625397ad9b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/3e5c092c0d78/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/b3c5a8aa0a5c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/c367c6fd1bca/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/c85cef05def2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f6/9092391/04625397ad9b/gr4.jpg

相似文献

1
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.宿主与 SARS-CoV-2 的较量:固有免疫与病毒逃逸策略。
Mol Ther. 2022 May 4;30(5):1869-1884. doi: 10.1016/j.ymthe.2022.02.014. Epub 2022 Feb 14.
2
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.SARS-CoV-2 介导的抗病毒干扰素途径的逃逸策略。
J Microbiol. 2022 Mar;60(3):290-299. doi: 10.1007/s12275-022-1525-1. Epub 2022 Feb 5.
3
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?SARS-CoV-2 逃避干扰素系统:我们能否恢复其有效性?
Int J Mol Sci. 2023 May 27;24(11):9353. doi: 10.3390/ijms24119353.
4
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.SARS-CoV-2 非结构蛋白及其在宿主免疫逃逸中的作用。
Viruses. 2022 Sep 8;14(9):1991. doi: 10.3390/v14091991.
5
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.SARS-CoV-2 抗病毒免疫逃逸的机制。
J Mol Biol. 2022 Mar 30;434(6):167265. doi: 10.1016/j.jmb.2021.167265. Epub 2021 Sep 22.
6
Interferon antagonists encoded by SARS-CoV-2 at a glance.一眼看懂 SARS-CoV-2 编码的干扰素拮抗剂。
Med Microbiol Immunol. 2023 Apr;212(2):125-131. doi: 10.1007/s00430-022-00734-9. Epub 2022 Apr 2.
7
Mechanisms of impairment of interferon production by SARS-CoV-2.SARS-CoV-2 损害干扰素产生的机制。
Biochem Soc Trans. 2023 Jun 28;51(3):1047-1056. doi: 10.1042/BST20221037.
8
Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options.SARS-CoV-2 逃逸的特征:干扰素途径和治疗选择。
Viruses. 2022 Jun 8;14(6):1247. doi: 10.3390/v14061247.
9
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.SARS-CoV-2 引发的固有免疫反应的逃逸和过度激活:一枚硬币的两面。
Viruses. 2022 Mar 4;14(3):530. doi: 10.3390/v14030530.
10
SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.德尔塔变异株 SARS-CoV-2 强烈抑制先天免疫反应并逃避人结肠上皮细胞中干扰素激活的抗病毒反应。
Microbiol Spectr. 2022 Oct 26;10(5):e0160422. doi: 10.1128/spectrum.01604-22. Epub 2022 Sep 8.

引用本文的文献

1
Dynamics of Innate Immunity in SARS-CoV-2 Infections: Exploring the Impact of Natural Killer Cells, Inflammatory Responses, Viral Evasion Strategies, and Severity.新型冠状病毒感染中固有免疫的动力学:探究自然杀伤细胞、炎症反应、病毒逃避策略及疾病严重程度的影响
Cells. 2025 May 22;14(11):763. doi: 10.3390/cells14110763.
2
Myeloid-Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID-19.髓系驱动的免疫抑制破坏了重症 COVID-19 中的中和抗体和 T 细胞免疫。
J Med Virol. 2025 Apr;97(4):e70335. doi: 10.1002/jmv.70335.
3
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV.

本文引用的文献

1
Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation.高致病性冠状病毒 N 蛋白通过 MASP-2 介导的凝集素补体途径过度激活加重炎症。
Signal Transduct Target Ther. 2022 Sep 14;7(1):318. doi: 10.1038/s41392-022-01133-5.
2
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.通过 CRISPR/Cas9 筛选鉴定 DAXX 为 SARS-CoV-2 的限制因子。
Nat Commun. 2022 May 4;13(1):2442. doi: 10.1038/s41467-022-30134-9.
3
SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis.
联合疗法增强了干扰素-λ对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和中东呼吸综合征冠状病毒(MERS-CoV)的抗病毒活性。
Virus Res. 2025 May;355:199560. doi: 10.1016/j.virusres.2025.199560. Epub 2025 Mar 18.
4
Changes in Circulating Adipokine Levels in COVID-19 Patients.新冠病毒肺炎患者循环中脂肪因子水平的变化
J Clin Med. 2024 Aug 14;13(16):4784. doi: 10.3390/jcm13164784.
5
In Silico Exploration of CD200 as a Therapeutic Target for COVID-19.CD200作为COVID-19治疗靶点的计算机模拟研究
Microorganisms. 2024 Jun 12;12(6):1185. doi: 10.3390/microorganisms12061185.
6
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.新冠疫情期间和之后对 SARS-CoV-2 发病机制的新认识。
Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.
7
Developing Next-Generation Live Attenuated Vaccines for Porcine Epidemic Diarrhea Using Reverse Genetic Techniques.利用反向遗传技术研发猪流行性腹泻下一代减毒活疫苗。
Vaccines (Basel). 2024 May 19;12(5):557. doi: 10.3390/vaccines12050557.
8
Protective effects of Jing-Si-herbal-tea in inflammatory cytokines-induced cell injury on normal human lung fibroblast multiomic platform analysis.经丝凉茶对炎症细胞因子诱导的正常人肺成纤维细胞损伤的保护作用:多组学平台分析
Tzu Chi Med J. 2024 Mar 26;36(2):152-165. doi: 10.4103/tcmj.tcmj_267_23. eCollection 2024 Apr-Jun.
9
The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.在重症 SARS-CoV-2 感染患者中,共抑制受体在 B 细胞失调中的作用。
J Immunol. 2024 May 15;212(10):1540-1552. doi: 10.4049/jimmunol.2300783.
10
Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy.多酚对新冠并发症的作用:当前证据与潜在疗效
Pharmacol Rep. 2024 Apr;76(2):307-327. doi: 10.1007/s43440-024-00585-6. Epub 2024 Mar 18.
SARS-CoV-2 3CLpro 全人蛋白质组切割预测及丰度/耗竭分析。
Comput Biol Chem. 2022 Jun;98:107671. doi: 10.1016/j.compbiolchem.2022.107671. Epub 2022 Mar 28.
4
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.SARS-CoV-2 病毒蛋白 3a 通过编码的 viroporin 触发 NLRP3 炎症途径。
Virology. 2022 Mar;568:13-22. doi: 10.1016/j.virol.2022.01.003. Epub 2022 Jan 17.
5
The SARS-CoV-2 main protease M causes microvascular brain pathology by cleaving NEMO in brain endothelial cells.SARS-CoV-2 主蛋白酶 M 通过裂解脑内皮细胞中的 NEMO 引起微血管性脑病理。
Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1. Epub 2021 Oct 21.
6
ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling Elevating Suppressor of Cytokine Signaling 1.严重急性呼吸综合征冠状病毒2的ORF3a蛋白抑制干扰素激活的Janus激酶/信号转导子和转录激活子信号通路,上调细胞因子信号转导抑制因子1。
Front Microbiol. 2021 Sep 28;12:752597. doi: 10.3389/fmicb.2021.752597. eCollection 2021.
7
Differential roles of RIG-I like receptors in SARS-CoV-2 infection.RIG-I 样受体在 SARS-CoV-2 感染中的差异作用。
Mil Med Res. 2021 Sep 7;8(1):49. doi: 10.1186/s40779-021-00340-5.
8
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response.SARS-CoV-2 核衣壳蛋白在调节固有免疫反应中的双重作用。
Signal Transduct Target Ther. 2021 Sep 1;6(1):331. doi: 10.1038/s41392-021-00742-w.
9
Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.蛋白酶切割 RNF20 可通过稳定 SREBP1 促进冠状病毒复制。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2107108118.
10
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.上呼吸道预先激活的抗病毒先天免疫可控制儿童早期 SARS-CoV-2 感染。
Nat Biotechnol. 2022 Mar;40(3):319-324. doi: 10.1038/s41587-021-01037-9. Epub 2021 Aug 18.